Newsroom

JACKSONVILLE, Fla.--(BUSINESS WIRE)--FIS® (NYSE: FIS), a global leader in financial technology, today announced the launch of its first offering to enable agentic commerce on the heels of announcing the close of the acquisition of its FIS Total Issuing™ Solutions portfolio. FIS’ new agentic commerce offering is the first to enable banks to safely and securely conduct commerce with AI agents and card networks. In agentic commerce transactions, AI functions as a personal digital assistant that ca...

MENTONE, Texas--(BUSINESS WIRE)--Independence Power Holdings (OTC: ITXP) announces its transition to a public-reporting company following a completed business combination....

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today provided a business update and announced strategic priorities for 2026, highlighting recent progress for its two lead programs, upcoming clinical milestones, and a strong financial position supporting execution through key value-inflection points. “We continue...

NEW YORK--(BUSINESS WIRE)--MindMed Announces Rebrand to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026...

AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ:HYFT) (« MindWalk » ou la « société »), une société d'IA bio-native spécialisée dans la recherche et les technologies thérapeutiques, annonce aujourd’hui une avancée dans son programme universel de lutte contre la grippe à la suite de l’identification d’une contrainte fonctionnelle révolutionnaire qui persiste à travers les virus de la grippe malgré une évolution continue. En utilisant sa technologie brevetée HYFT® Deep Data, MindW...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer (“CEO”), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and ef...

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced highlights from the Company's 2025 achievements and provided additional updates on key milestones expected in 2026. Ionis will provide a business update at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 8:15am PT; the presentation is available today on the Ionis website here. “2025 was a defining year for Ionis, as we successfully executed our first two independent launches...

CHARLESTON, W.V.--(BUSINESS WIRE)--Surya Oil & Gas Corp. (“Surya” or the “Company”) (OTCID: SURY) today announces the appointment of William T. “Bill” Devereux as Chief Financial Officer and Treasurer, as the Company advances from planning to execution across its oil and gas portfolio. Initial redevelopment activity on Surya’s West Virginia wells is expected to commence in the first quarter of 2026, with the Company positioning its broader acreage, including Texas, for subsequent phases of...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--FIS® (NYSE: FIS), a global leader in financial technology, today announced the completion of its acquisition of Global Payments' Issuer Solutions business, formerly known as TSYS, for an enterprise value of $13.5 billion, or a net purchase price of $12 billion including $1.5 billion of net present value of tax assets. Offerings from this asset, the world’s largest issuing business, will now go to market under the FIS® Total Issuing™ Solutions portfolio brand...

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial and operational results for the quarter and full year ended December 31, 2025. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, Tumor Treating Fields (TTFields). “Novocure exits 2025 having achieved record annual revenue, providing the financial strength to execute on th...